Yıl: 2022 Cilt: 52 Sayı: 3 Sayfa Aralığı: 762 - 769 Metin Dili: İngilizce DOI: 10.55730/1300-0144.5371 İndeks Tarihi: 27-07-2022

Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma

Öz:
Background/aim: In this single-center study, we aimed to analyze texture features of primary uterine lesions on 18F-FDG PET/CT to predict lymph node metastases. Material and methods: Totally, 157 (mean age: 62 ± 10.2 years) patients were included in the analysis. Histopathological examination results were considered as the standard reference for nodal involvement. On $^{18}F-FDG PET/CT$ images, only the primary tumor was segmented. SUVmax, SUVmean, SUVpeak, MTV, and TLG of primary uterine lesions were calculated for analyses. For texture analysis first, second, and higher-order texture features were calculated. Results: Mean diameter of primary uterine lesions was calculated as 35± 18.1 mm. Lymph node metastases were detected in 19% of patients in histopathological examination of surgical materials. While 26 patients had pelvic lymph node metastases, 19 patients had additional paraaortic lymph node metastases. On radiomics analysis for 20 features, a significant difference was found between patients with and without lymph node metastasis. With using data mining methods GLZLM ZLNU, EntropyGLCM, Entropyhisto, GLRLM LRHGE, GLZLM HGZE, GLZLM SZHGE, GLRLM HGRE, GLRLM SRHGE were found significant radiomics features to predict lymph node metastasis with a diagnostic accuracy of 0.8. Conclusion: The radiomics analysis of intratumoral heterogeneity is a promising method for improving triage of the patients for lymph node dissection in endometrial carcinoma.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer 2015; 136 (5): E359-386. doi: 10.1002/ijc.29210
  • 2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC et al. Cancer statistics. CA A Cancer Jornal of Clinicians 2005; 55 (1): 10-30. doi: 10.3322/canjclin.55.1.10
  • 3. Lewin SN, Herzog TJ, Medel NIB, Deutsch I, Burke WM et al. Comparative performance of the 2009 international federation of gynecology and obstetrics’ staging system for uterine corpus cancer. Obstetrics and Gynecology 2010; 116 (5): 1141-1149. doi: 10.1097/AOG.0b013e3181f39849
  • 4. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecological Oncology 2008; 109: 11-18. doi: 10.1016/j. ygyno.2008.01.023
  • 5. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecological Oncology 2012; 127: 5-10. doi: 10.1016/j. ygyno.2012.06.035
  • 6. Seracchioli R, Solfrini S, Mabrouk M, Facchini C, Di Donato N et al. Controversies in surgical staging of endometrial cancer. Obstetrics and Gynecology International 2010; 2010: 181963. doi: 10.1155/2010/181963
  • 7. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009; 373 (9658): 125-136. doi 10.1016/S0140-6736(08)61766-3
  • 8. Crivellaro C, Baratto L, Dolci C, De Ponti E, Magni S et al. Sentinel node biopsy in endometrial cancer: an update. Clinical Translational Imaging 2018; 6 (2): 91-100. doi: 10.1007/s40336- 018-0268-9
  • 9. Türkmen O, Başaran D, Karalök A, Cömert Kimyon G, Taşçı T et al. Prognostic effect of isolated paraaortic nodal spread in endometrial cancer. Journal of the Turkish-German Gynecological Association 2018; 19 (4): 201-205. doi: 10.4274/ jtgga.2017.0152
  • 10. Taskın S, Sarı ME, Altın D, Ersöz CC, Gökçe A et al. Risk factors for failure of sentinel lymph node mapping using indocyanine green/near-infrared fluorescent imaging in endometrial cancer. Archives of Gynecology and Obstetrics 2019; 299 (6): 1667-1672. doi: 10.1007/s00404-019-05137-5
  • 11. Signorelli M, Crivellaro C, Buda A, Guerra L, Fruscio R et al. Staging of high-risk endometrial cancer with PET/CT and sentinel lymph node mapping. Clinical Nuclear Medicine 2015; 40 (10): 780-785. doi: 10.1097/RLU.0000000000000852
  • 12. Lee JW, Lee SM. Radiomics in Oncological PET/CT: Clinical Applications. Nuclear Medicine and Molecular Imaging 2018; 52 (3): 170-189. doi: 10.1007/s13139-017-0500-y
  • 13. De Bernardi E, Buda A, Guerra L, Vicini D, Elisei F et al. Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer European Journal of Nuclear Medicine and Molecular Imaging Research. 2018; 8: 86. doi: 10.1186/s13550- 018-0441-1
  • 14. Crivellaro C, Landoni C, Elisei F, Buda A, Bonacina M et al. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients. International Journal of Gynecological Cancer 2020; 30 (3): 378-382. doi: 10.1136/ijgc-2019-000945
  • 15. Hatt M, Tixier F, Visvikis D, Le Rest CC. Radiomics in PET/ CT: more than meets the eye? Journal of Nuclear Medicine 2017; 58: 365-366. doi: 10.2967/jnumed.116.184655
  • 16. Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG et al. Radiomics: extracting more information from medical images using advanced feature analysis. European Journal of Cancer 2012; 48: 441-446. doi: 10.1016/j. ejca.2011.11.036
  • 17. Nakamura K, Hongo A, Kodama J, Hiramatsu Y. The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer. Gynecological Oncology 2011; 123(1): 82-87. doi: 10.1016/j. ygyno.2011.06.026
  • 18. Nakamura K, Kodama J, Okumura Y, Hongo A, Kanazawa S et al. The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer. International Journal of Gynecological Cancer. 2010; 20 (1): 110-115. doi: 10.1111/ IGC.0b013e3181c3a288
  • 19. Crivellaro C, Signorelli M, Guerra L, De Ponti E, Pirovano C et al. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT. Gynecological Oncology 2013; 130 (2): 306–311. doi: 10.1016/j.ygyno.2013.05.011
  • 20. Hyun SH, Ahn MS, Koh YW, Lee SJ. A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer, Clinical Nuclear Medicine 2019; 44: 956-960. doi: 10.1097/RLU.0000000000002810
  • 21. Acar E, Turgut B, Yigit S, Kaya GC. Comparison of the volumetric and radiomics findings of 18F-FDG PET/CT images with immunohistochemical prognostic factors in local/locally advanced breast cancer. Nuclear Medicine Communications 2019; 40: 764-772. doi: 10.1097/MNM.0000000000001019
  • 22. Wang M, Xu H, Xiao L, Song W, Zhu S et al. Prognostic Value of Functional Parameters of 18 F-FDG-PET Images in Patients With Primary Renal/Adrenal Lymphoma, Contrast Media and Molecular Imaging 2019; 2641627. doi: 10.1155/2019/2641627
  • 23. https://towardsdatascience.com/5-reasons-why-youshould-use-cross-validation-in-your-data-science-project8163311a1e79.
APA Soydal C, Varli B, Araz M, Bakırarar B, Taşkın S, ortaç f (2022). Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma. , 762 - 769. 10.55730/1300-0144.5371
Chicago Soydal Cigdem,Varli Bulut,Araz Mine,Bakırarar Batuhan,Taşkın Salih,ortaç fırat Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma. (2022): 762 - 769. 10.55730/1300-0144.5371
MLA Soydal Cigdem,Varli Bulut,Araz Mine,Bakırarar Batuhan,Taşkın Salih,ortaç fırat Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma. , 2022, ss.762 - 769. 10.55730/1300-0144.5371
AMA Soydal C,Varli B,Araz M,Bakırarar B,Taşkın S,ortaç f Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma. . 2022; 762 - 769. 10.55730/1300-0144.5371
Vancouver Soydal C,Varli B,Araz M,Bakırarar B,Taşkın S,ortaç f Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma. . 2022; 762 - 769. 10.55730/1300-0144.5371
IEEE Soydal C,Varli B,Araz M,Bakırarar B,Taşkın S,ortaç f "Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma." , ss.762 - 769, 2022. 10.55730/1300-0144.5371
ISNAD Soydal, Cigdem vd. "Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma". (2022), 762-769. https://doi.org/10.55730/1300-0144.5371
APA Soydal C, Varli B, Araz M, Bakırarar B, Taşkın S, ortaç f (2022). Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma. Turkish Journal of Medical Sciences, 52(3), 762 - 769. 10.55730/1300-0144.5371
Chicago Soydal Cigdem,Varli Bulut,Araz Mine,Bakırarar Batuhan,Taşkın Salih,ortaç fırat Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma. Turkish Journal of Medical Sciences 52, no.3 (2022): 762 - 769. 10.55730/1300-0144.5371
MLA Soydal Cigdem,Varli Bulut,Araz Mine,Bakırarar Batuhan,Taşkın Salih,ortaç fırat Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma. Turkish Journal of Medical Sciences, vol.52, no.3, 2022, ss.762 - 769. 10.55730/1300-0144.5371
AMA Soydal C,Varli B,Araz M,Bakırarar B,Taşkın S,ortaç f Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma. Turkish Journal of Medical Sciences. 2022; 52(3): 762 - 769. 10.55730/1300-0144.5371
Vancouver Soydal C,Varli B,Araz M,Bakırarar B,Taşkın S,ortaç f Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma. Turkish Journal of Medical Sciences. 2022; 52(3): 762 - 769. 10.55730/1300-0144.5371
IEEE Soydal C,Varli B,Araz M,Bakırarar B,Taşkın S,ortaç f "Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma." Turkish Journal of Medical Sciences, 52, ss.762 - 769, 2022. 10.55730/1300-0144.5371
ISNAD Soydal, Cigdem vd. "Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma". Turkish Journal of Medical Sciences 52/3 (2022), 762-769. https://doi.org/10.55730/1300-0144.5371